Ashton Easterday

Ashton Easterday is a highly skilled scientist specializing in Drug Metabolism and Pharmacokinetics (DMPK) with a progressive career spanning over a decade. Currently serving as Scientist II at Cytokinetics since August 2023, Ashton previously held roles at ChemoCentryx (acquired by Amgen) as Scientist and Senior Associate Scientist in DMPK from August 2019 to February 2023. Additional experience includes contract DMPK work at Protagonist Therapeutics, a research role at Achaogen, and various positions at Signature Therapeutics and Santa Clara University. Ashton holds multiple relevant certifications from UC San Diego Extended Studies and advanced degrees in Human Nutritional Science and Chemistry from San José State University and Santa Clara University, respectively.